Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

MOSAEC
Author: MOSAEC

Source: BBC.

Written by

MOSAEC

in

More posts